Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Alnylam Pharma (0HD2) vs. Competitors

4 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GB:0HD2Alnylam Pharma$159.06$22.11B8.10-65.24%Moderate BuyUnlock the GB:0HD2 analyst price target with TipRanks PremiumGB:0HD2Unlock the GB:0HD2 top-analyst price target with TipRanks Premium
ARWRArrowhead Pharmaceuticals$44.21$6.75B-9.377.15%Strong BuyUnlock the ARWR analyst price target with TipRanks PremiumGB:0HD2 vs ARWRUnlock the ARWR top-analyst price target with TipRanks Premium
BMRNBioMarin Pharmaceutical$57.99$11.09B-635.895.96%Moderate BuyUnlock the BMRN analyst price target with TipRanks PremiumGB:0HD2 vs BMRNUnlock the BMRN top-analyst price target with TipRanks Premium
IONSIonis Pharmaceuticals$28.01$4.84B-8.75-60.85%Strong BuyUnlock the IONS analyst price target with TipRanks PremiumGB:0HD2 vs IONSUnlock the IONS top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$9.86$1.36B-2.9013.33%HoldUnlock the NTLA analyst price target with TipRanks PremiumGB:0HD2 vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
CRSPCrispr Therapeutics AG$40.37$4.10B-8.91-23.15%Moderate BuyUnlock the CRSP analyst price target with TipRanks PremiumGB:0HD2 vs CRSPUnlock the CRSP top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GB:0HD2Alnylam Pharma159.06-303.93-65.65%
ARWRArrowhead Pharmaceuticals44.214.0610.11%
BMRNBioMarin Pharmaceutical57.993.536.48%
IONSIonis Pharmaceuticals28.01-45.25-61.77%
NTLAIntellia Therapeutics9.861.3816.27%
CRSPCrispr Therapeutics AG40.37-14.95-27.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts